PreprintAll rights reservedbioRxiv
Sublingual Buprenorphine/Naloxone Film in Unanesthetized Rats: Feasibility, Tolerability, and Plasma Exposure
- 1University of Pittsburgh School of Medicine
Related
- A Measurement-Based Care Strategy for Buprenorphine-Naloxone Treatment (Bup-MBC): Development of an EHR-Integrated Intervention
- Buccal and sublingual lyophilised naloxone for opioid overdose reversal: A Phase 1 open-label, random-sequence crossover pharmacokinetic study protocol in healthy volunteers (NalBuc)
- Comparative efficacy of naltrexone-accelerated versus sublingual buprenorphine in opioid withdrawal management and initiating injectable naltrexone treatment: study protocol for a randomized controlled trial.
- Stroboscopic Light Stimulation in Adults Reporting Depressive Symptoms: Safety, Tolerability, Feasibility, and Active-Comparator Development in a Staged Early-Phase Study
- Development of an In Vitro Permeation Test Framework For Naloxone Hydrochloride Intranasal Spray: Establishing IVIVR for Bioequivalence Assessment
BibTeX
@misc{wang2026sublingual,
title = {{Sublingual Buprenorphine/Naloxone Film in Unanesthetized Rats: Feasibility, Tolerability, and Plasma Exposure}},
author = {Y. Wang and Q. Chen and T. Deakin and T. Emerick and Y. Xu and P. Tang},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.30.763075},
url = {https://www.biorxiv.org/content/10.64898/2026.10.30.763075v1},
}
RIS
TY - UNPB
TI - Sublingual Buprenorphine/Naloxone Film in Unanesthetized Rats: Feasibility, Tolerability, and Plasma Exposure
AU - Y. Wang
AU - Q. Chen
AU - T. Deakin
AU - T. Emerick
AU - Y. Xu
AU - P. Tang
PY - 2026
DA - 2026/10/30
PB - bioRxiv
DO - 10.64898/2026.10.30.763075
UR - https://www.biorxiv.org/content/10.64898/2026.10.30.763075v1
ER -